Brandes Investment Partners’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$692K Buy
2,409
+585
+32% +$168K 0.01% 176
2025
Q1
$562K Buy
1,824
+340
+23% +$105K 0.01% 179
2024
Q4
$524K Sell
1,484
-10,210
-87% -$3.6M 0.01% 184
2024
Q3
$4.19M Sell
11,694
-8,222
-41% -$2.95M 0.05% 128
2024
Q2
$6.33M Buy
19,916
+926
+5% +$294K 0.08% 114
2024
Q1
$4.36M Buy
18,990
+2,897
+18% +$665K 0.06% 117
2023
Q4
$3.54M Buy
16,093
+884
+6% +$194K 0.05% 119
2023
Q3
$3.44M Buy
15,209
+689
+5% +$156K 0.07% 115
2023
Q2
$3.21M Sell
14,520
-110
-0.8% -$24.3K 0.06% 115
2023
Q1
$3.28M Buy
14,630
+4,670
+47% +$1.05M 0.07% 115
2022
Q4
$2.77M Sell
9,960
-9,546
-49% -$2.65M 0.08% 84
2022
Q3
$4.08M Sell
19,506
-1,599
-8% -$335K 0.11% 110
2022
Q2
$4.97M Buy
21,105
+1,096
+5% +$258K 0.12% 110
2022
Q1
$3.59M Buy
20,009
+1,432
+8% +$257K 0.08% 113
2021
Q4
$4.02M Sell
18,577
-276
-1% -$59.7K 0.09% 113
2021
Q3
$3.48M Buy
18,853
+476
+3% +$87.9K 0.08% 110
2021
Q2
$3.3M Sell
18,377
-12
-0.1% -$2.15K 0.07% 110
2021
Q1
$3.04M Sell
18,389
-14,148
-43% -$2.34M 0.07% 108
2020
Q4
$4.84M Sell
32,537
-27,255
-46% -$4.05M 0.12% 92
2020
Q3
$6.04M Sell
59,792
-16,571
-22% -$1.67M 0.21% 82
2020
Q2
$9.24M Sell
76,363
-216,033
-74% -$26.1M 0.28% 77
2020
Q1
$27.7M Buy
292,396
+1,414
+0.5% +$134K 0.97% 38
2019
Q4
$25.6M Sell
290,982
-6,131
-2% -$540K 0.61% 54
2019
Q3
$23.7M Buy
297,113
+74,963
+34% +$5.98M 0.61% 56
2019
Q2
$17.3M Buy
222,150
+176,048
+382% +$13.7M 0.39% 66
2019
Q1
$5.41M Buy
46,102
+2,227
+5% +$261K 0.13% 85
2018
Q4
$4.78M Buy
43,875
+15,111
+53% +$1.65M 0.12% 89
2018
Q3
$3.68M Sell
28,764
-1,011
-3% -$129K 0.08% 95
2018
Q2
$3.37M Buy
29,775
+2,845
+11% +$322K 0.08% 96
2018
Q1
$3.03M Buy
26,930
+13,217
+96% +$1.49M 0.06% 97
2017
Q4
$2.03M Buy
+13,713
New +$2.03M 0.04% 119